QXO Inc (QXO) concluded trading on Wednesday at a closing price of $22.03, with 7.26 million shares of worth about $159.94 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 38.12% during that period and on July 09, 2025 the price saw a gain of about 1.76%. Currently the company’s common shares owned by public are about 670.33M shares, out of which, 590.65M shares are available for trading.
Stock saw a price change of 4.01% in past 5 days and over the past one month there was a price change of 15.95%. Year-to-date (YTD), QXO shares are showing a performance of -63.89% which increased to 38.55% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.61 but also hit the highest price of $157.28 during that period. The average intraday trading volume for QXO Inc shares is 9.01 million. The stock is currently trading 2.48% above its 20-day simple moving average (SMA20), while that difference is up 21.67% for SMA50 and it goes to 42.36% higher than SMA200.
QXO Inc (NYSE: QXO) currently have 670.33M outstanding shares and institutions hold larger chunk of about 50.45% of that.
The stock has a current market capitalization of $14.77B and its 3Y-monthly beta is at 2.35. It has posted earnings per share of -$0.96 in the same period. It has Quick Ratio of 95.23 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for QXO, volatility over the week remained 2.86% while standing at 4.63% over the month.
Stock’s fiscal year EPS is expected to rise by 455.31% while it is estimated to increase by 46.99% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Truist on July 01, 2025 offering a Buy rating for the stock and assigned a target price of $30 to it. On June 12, 2025, Robert W. Baird Initiated their recommendations, while on June 11, 2025, Oppenheimer Initiated their ratings for the stock with a price target of $27. Stock get an Outperform rating from Wolfe Research on June 06, 2025.
